Rafael Holdings, Inc.(RFL)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-06-09 | JONAS HOWARD S Exec Chairman, CEO & President | Purchase | +13,080,457 | +813.19%14,688,994 | $1.28 | $16,742,985 | View SEC filing | |
| 2022-08-09 | JONAS HOWARD S Executive Chairman | Sale | -112,561 | -3.37%3,225,806 | $1.88 | $211,645 | View SEC filing | |
| 2022-08-09 | i9 PLUS, LLC 10% Owner | Sale | -112,561 | -3.37%3,225,806 | $1.88 | $211,645 | View SEC filing | |
| 2022-07-07 | JONAS HOWARD S Executive Chairman | Purchase | +3,225,806 | +2865.83%3,338,367 | $1.86 | $5,999,999 | View SEC filing | |
| 2021-08-25 | JONAS HOWARD S Chief Executive Officer | Purchase | +112,561 | +100.00%112,561 | $44.92 | $5,056,240 | View SEC filing |
1-5 of 5